Cargando…

The immunoproteasome subunit LMP10 mediates angiotensin II-induced retinopathy in mice

Inflammation has been implicated in a variety of retinal diseases. The immunoproteasome plays a critical role in controlling inflammatory responses, but whether activation of immunoproteasome contributes to angiotensin II (Ang II)-induced retinopathy remains unclear. Hypertensive retinopathy (HR) wa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Shuai, Li, Jing, Bai, Jie, Li, Jing-Min, Che, Yi-Lin, Lin, Qiu-Yue, Zhang, Yun-Long, Li, Hui-Hua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5952914/ https://www.ncbi.nlm.nih.gov/pubmed/29499566 http://dx.doi.org/10.1016/j.redox.2018.02.022

Ejemplares similares

Deficiency of the Immunoproteasome LMP10 Subunit Attenuates Angiotensin II-Induced Cardiac Hypertrophic Remodeling via Autophagic Degradation of gp130 and IGF1R
por: Yan, Wen, et al.
Publicado: (2020)

Co-Inhibition of the Immunoproteasome Subunits LMP2 and LMP7 Ameliorates Immune Thrombocytopenia
por: Du, Sheng-hong, et al.
Publicado: (2021)

Immunohistochemical Identification and Assessment of the Location of Immunoproteasome Subunits LMP2 and LMP7 in Acquired Cholesteatoma
por: Rutkowska, Justyna, et al.
Publicado: (2023)

Immunoproteasome subunit LMP7 Deficiency Improves Obesity and Metabolic Disorders
por: Kimura, Hiroaki, et al.
Publicado: (2015)

Immunoproteasome subunit ß5i/LMP7-deficiency in atherosclerosis
por: Hewing, Bernd, et al.
Publicado: (2017)

The Immunoproteasome Subunits LMP2, LMP7 and MECL-1 Are Crucial Along the Induction of Cerebral Toxoplasmosis
por: French, Timothy, et al.
Publicado: (2021)

Prevention of colitis-associated cancer by selective targeting of immunoproteasome subunit LMP7
por: Vachharajani, Niyati, et al.
Publicado: (2017)

Airway epithelial immunoproteasome subunit LMP7 protects against rhinovirus infection
por: Dimasuay, Kris Genelyn, et al.
Publicado: (2022)

Induction of the Immunoproteasome Subunit Lmp7 Links Proteostasis and Immunity in α-Synuclein Aggregation Disorders
por: Ugras, Scott, et al.
Publicado: (2018)

Expression of Immunoproteasome Subunit LMP7 in Breast Cancer and Its Association with Immune-Related Markers
por: Lee, Miseon, et al.
Publicado: (2019)

Inhibition and deficiency of the immunoproteasome subunit LMP7 suppress the development and progression of colorectal carcinoma in mice
por: Koerner, Julia, et al.
Publicado: (2017)

Inhibition of the Immunoproteasome Subunit LMP7 Ameliorates Cerebral White Matter Demyelination Possibly via TGFβ/Smad Signaling
por: Chen, Xingyong, et al.
Publicado: (2021)

Impairment of Immunoproteasome Function by β5i/LMP7 Subunit Deficiency Results in Severe Enterovirus Myocarditis
por: Opitz, Elisa, et al.
Publicado: (2011)

A selective inhibitor of the immunoproteasome subunit LMP2 induces apoptosis in PC-3 cells and suppresses tumour growth in nude mice
por: Wehenkel, M, et al.
Publicado: (2012)

Nitric oxide-dependent CYP2B degradation is potentiated by a cytokine-regulated pathway and utilizes the immunoproteasome subunit LMP2
por: Sun, Haiyan, et al.
Publicado: (2012)

Ageing-related changes in the levels of β-catenin, CacyBP/SIP, galectin-3 and immunoproteasome subunit LMP7 in the heart of men
por: Kasacka, Irena, et al.
Publicado: (2020)

M3258 Is a Selective Inhibitor of the Immunoproteasome Subunit LMP7 (β5i) Delivering Efficacy in Multiple Myeloma Models
por: Sanderson, Michael P., et al.
Publicado: (2021)

Gallic Acid Ameliorates Angiotensin II-Induced Atrial Fibrillation by Inhibiting Immunoproteasome- Mediated PTEN Degradation in Mice
por: Han, Dan, et al.
Publicado: (2020)

Inhibition of the immunoproteasome LMP2 ameliorates ischemia/hypoxia-induced blood–brain barrier injury through the Wnt/β-catenin signalling pathway
por: Chen, Xing-Yong, et al.
Publicado: (2021)

Deficiency of LMP10 Attenuates Diet-Induced Atherosclerosis by Inhibiting Macrophage Polarization and Inflammation in Apolipoprotein E Deficient Mice
por: Liao, Jiawei, et al.
Publicado: (2020)

Comparative Assessment of the WNT/β-Catenin Pathway, CacyBP/SIP, and the Immunoproteasome Subunit LMP7 in Various Histological Types of Renal Cell Carcinoma
por: Piotrowska, Żaneta, et al.
Publicado: (2020)

Expression Pattern of Immunoproteasome Subunits in Human Thymus
por: Oh, Kwon Ik, et al.
Publicado: (2009)

The Functional and Mechanistic Roles of Immunoproteasome Subunits in Cancer
por: Tripathi, Satyendra Chandra, et al.
Publicado: (2021)

The immunoproteasome catalytic β5i subunit regulates cardiac hypertrophy by targeting the autophagy protein ATG5 for degradation
por: Xie, Xin, et al.
Publicado: (2019)

Angiotensin II Stimulates the Proliferation and Migration of Lymphatic Endothelial Cells Through Angiotensin Type 1 Receptors
por: Lin, Qiu-Yue, et al.
Publicado: (2020)

Resveratrol as a new inhibitor of immunoproteasome prevents PTEN degradation and attenuates cardiac hypertrophy after pressure overload
por: Chen, Chen, et al.
Publicado: (2018)

HIV-1 Nef Interacts with LMP7 To Attenuate Immunoproteasome Formation and Major Histocompatibility Complex Class I Antigen Presentation
por: Yang, Yang, et al.
Publicado: (2020)

Immunoproteasome impairment via β5i/LMP7‐deletion leads to sustained pancreatic injury from experimental pancreatitis
por: de Freitas Chama, Laura L., et al.
Publicado: (2021)

Angiotensin II Induces Cardiac Edema and Hypertrophic Remodeling through Lymphatic-Dependent Mechanisms
por: Bai, Jie, et al.
Publicado: (2022)

Apelin inhibited epithelial−mesenchymal transition of podocytes in diabetic mice through downregulating immunoproteasome subunits β5i
por: Yin, Jiming, et al.
Publicado: (2018)

Immunoproteasome LMP2 60HH Variant Alters MBP Epitope Generation and Reduces the Risk to Develop Multiple Sclerosis in Italian Female Population
por: Mishto, Michele, et al.
Publicado: (2010)

Immunoproteasome Assembly: Cooperative Incorporation of Interferon γ (IFN-γ)–inducible Subunits
por: Griffin, Thomas A., et al.
Publicado: (1998)

A Nut for Every Bolt: Subunit-Selective Inhibitors of the Immunoproteasome and Their Therapeutic Potential
por: Huber, Eva M., et al.
Publicado: (2021)

The Expression of the Immunoproteasome Subunit PSMB9 Is Related to Distinct Molecular Subtypes of Uterine Leiomyosarcoma
por: Maia Falcão, Raul, et al.
Publicado: (2022)

Immunoproteasome subunit β5i promotes perifascicular muscle atrophy in dermatomyositis by upregulating RIG-I
por: Zhang, Lu, et al.
Publicado: (2023)

Selective Inhibition of the Immunoproteasome β5i Prevents PTEN Degradation and Attenuates Cardiac Hypertrophy
por: Xie, Xin, et al.
Publicado: (2020)

Immunoproteasome Activity in Chronic Lymphocytic Leukemia as a Target of the Immunoproteasome-Selective Inhibitors
por: Besse, Andrej, et al.
Publicado: (2022)

The association between the genetic polymorphisms of LMP2/LMP7 and the outcomes of HCV infection among drug users()
por: Cui, Qian, et al.
Publicado: (2010)

Blocking VCAM-1 Prevents Angiotensin II-Induced Hypertension and Vascular Remodeling in Mice
por: Yin, Liangqingqing, et al.
Publicado: (2022)

Inhibition of the immunoproteasome ameliorates experimental autoimmune encephalomyelitis
por: Basler, Michael, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ipk17aac5hve808srsgd1tnsdn